» Articles » PMID: 34572488

Emergence of Cardiac Glycosides As Potential Drugs: Current and Future Scope for Cancer Therapeutics

Overview
Journal Biomolecules
Publisher MDPI
Date 2021 Sep 28
PMID 34572488
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac glycosides are natural sterols and constitute a group of secondary metabolites isolated from plants and animals. These cardiotonic agents are well recognized and accepted in the treatment of various cardiac diseases as they can increase the rate of cardiac contractions by acting on the cellular sodium potassium ATPase pump. However, a growing number of recent efforts were focused on exploring the antitumor and antiviral potential of these compounds. Several reports suggest their antitumor properties and hence, today cardiac glycosides (CG) represent the most diversified naturally derived compounds strongly recommended for the treatment of various cancers. Mutated or dysregulated transcription factors have also gained prominence as potential therapeutic targets that can be selectively targeted. Thus, we have explored the recent advances in CGs mediated cancer scope and have considered various signaling pathways, molecular aberration, transcription factors (TFs), and oncogenic genes to highlight potential therapeutic targets in cancer management.

Citing Articles

Drug Repurposing for Cancer Treatment: A Comprehensive Review.

Al Khzem A, Gomaa M, Alturki M, Tawfeeq N, Sarafroz M, Alonaizi S Int J Mol Sci. 2024; 25(22).

PMID: 39596504 PMC: 11595001. DOI: 10.3390/ijms252212441.


Simplified Method for Kinetic and Thermodynamic Screening of Cardiotonic Steroids through the K-Dependent Phosphatase Activity of Na/K-ATPase with Chromogenic pNPP Substrate.

Azalim-Neto P, Noel F, Silva S, Villar J, Barbosa L, ODoherty G Mol Pharmacol. 2024; 106(5):225-239.

PMID: 39187390 PMC: 11493336. DOI: 10.1124/molpharm.124.000934.


Tapping the potential of hairy roots for cardiac glycosides production and their identification using UHPLC/QTOF-MS.

Djerdjouri A, Abbad M, Boumrah Y, Malik S, Makhzoum A, Lakhdar K 3 Biotech. 2024; 14(9):199.

PMID: 39144068 PMC: 11319682. DOI: 10.1007/s13205-024-04035-1.


Digitoxin inhibits ICC cell properties via the NF‑κB/ST6GAL1 signaling pathway.

Zhan Y, Wang R, Huang C, Xu X, Xiao X, Wu L Oncol Rep. 2024; 52(2).

PMID: 38940341 PMC: 11229393. DOI: 10.3892/or.2024.8762.


PBI-05204, a supercritical CO extract of Nerium oleander, suppresses glioblastoma stem cells by inhibiting GRP78 and inducing programmed necroptotic cell death.

Chakraborty S, Wei D, Tran M, Lang F, Newman R, Yang P Neoplasia. 2024; 54:101008.

PMID: 38823209 PMC: 11177059. DOI: 10.1016/j.neo.2024.101008.


References
1.
Winnicka K, Bielawski K, Bielawska A, Miltyk W . Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells. Arch Pharm Res. 2007; 30(10):1216-24. DOI: 10.1007/BF02980262. View

2.
Semenza G . Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3(10):721-32. DOI: 10.1038/nrc1187. View

3.
Zhang Q, Wang F, Jia K, Kong L . Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects. Front Pharmacol. 2018; 9:1253. PMC: 6232953. DOI: 10.3389/fphar.2018.01253. View

4.
Cunha Filho G, Schwartz C, Resck I, Murta M, Lemos S, Castro M . Antimicrobial activity of the bufadienolides marinobufagin and telocinobufagin isolated as major components from skin secretion of the toad Bufo rubescens. Toxicon. 2005; 45(6):777-82. DOI: 10.1016/j.toxicon.2005.01.017. View

5.
Bielawski K, Winnicka K, Bielawska A . Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A. Biol Pharm Bull. 2006; 29(7):1493-7. DOI: 10.1248/bpb.29.1493. View